Immix BiopharmaIMMX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 31 institutions reported holding Immix Biopharma Inc. (IMMX) in their 13F filings, down 4 from Q1 2024. 5 opened new positions and 6 sold out. The largest holders were AIGH Capital Management LLC ($2.8M), Bleichroeder LP ($1.7M) and Cable Car Capital, LP ($1.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Immix Biopharma Inc.
- CUSIP
- 45258H106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $129K |
| Exits | 6 | $480K |
All 13F filers, Q1 2024 → Q2 2024: 359,865 shares bought and 576,761 shares sold, net −216,896 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| AIGH Capital Management LLC | 1.36% | Reduce -9.5% | 1,406,680 | $2.8M |
| Bleichroeder LP | 0.50% | No change | 850,000 | $1.7M |
| Cable Car Capital, LP | 1.73% | Add +18.7% | 796,100 | $1.6M |
| Vanguard Group Inc. | 0.00% | Add +31.2% | 598,537 | $1.2M |
| Renaissance Technologies | 0.00% | Reduce -41.7% | 154,685 | $306K |
| Geode Capital Management, LLC | 0.00% | Add +13.9% | 142,128 | $281K |
| Private Advisor Group, LLC | 0.00% | Reduce -34.0% | 65,175 | $129K |
| Morgan Stanley | 0.00% | Add +8.2% | 58,457 | $116K |
| State Street Corp. | 0.00% | No change | 42,960 | $85K |
| Northern Trust Corp. | 0.00% | No change | 38,914 | $77K |
| Tocqueville Asset Management L.P. | 0.00% | No change | 37,800 | $75K |
| FNY Investment Advisers, LLC | 0.04% | Add +27.4% | 32,500 | $64K |
| Invst, LLC | 0.01% | New | 27,000 | $57K |
| Millennium Management | 0.00% | Reduce -51.5% | 26,300 | $52K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 26,080 | $52K |
| Tritonpoint Wealth, LLC | 0.00% | No change | 24,526 | $49K |
| Squarepoint Ops LLC | 0.00% | New | 23,010 | $46K |
| XTX Topco Ltd | 0.00% | Reduce -66.2% | 17,663 | $35K |
| Corsair Capital Management, L.P. | 0.00% | Reduce -79.5% | 14,217 | $28K |
| BlackRock Inc. | 0.00% | Reduce -30.4% | 13,455 | $27K |
| Focus Partners Wealth | 0.00% | New | 11,900 | $24K |
| Old National Bancorp | 0.00% | No change | 10,000 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.0% | 3,986 | $8K |
| UBS Group AG | 0.00% | Reduce -40.0% | 3,154 | $6K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 1,492 | $3K |
| Tortoise Investment Management, LLC | 0.00% | No change | 1,300 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 950 | $2K |
| Wells Fargo & Company | 0.00% | Reduce -24.0% | 330 | $653 |
| Bank of America Corp. | 0.00% | New | 115 | $228 |
| Royal Bank of Canada | 0.00% | Add +2116.7% | 133 | $0 |
| Simplex Trading, LLC | 0.00% | Reduce -11.8% | 449 | $0 |
"% of holder's portfolio" is IMMX's weight in each manager's 13F, not the share of Immix Biopharma Inc. the manager owns.